---
title: "BLGO.US (BLGO.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/BLGO.US/news.md"
symbol: "BLGO.US"
name: "BLGO.US"
parent: "https://longbridge.com/zh-CN/quote/BLGO.US.md"
datetime: "2026-03-15T06:36:06.745Z"
locales:
  - [en](https://longbridge.com/en/quote/BLGO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BLGO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BLGO.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/BLGO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BLGO.US/news.md)


# BLGO.US (BLGO.US) — 相关新闻

### [BioLargo Issues Investor Presentation Under Regulation FD Disclosure](https://longbridge.com/zh-CN/news/277981400.md)
*2026-03-05T19:57:32.000Z*
> BioLargo, Inc. (BLGO) announced an investor presentation scheduled for March 5, 2026, at 9:00 a.m. PT, along with a pres

### [BioLargo reports $3.9M year-end cash, 2025 revenue $7.8M and $15.2M net loss](https://longbridge.com/zh-CN/news/277979821.md)
*2026-03-05T19:33:01.000Z*
> BioLargo reported a year-end cash balance of $3.9 million and projected 2025 revenue of $7.8 million, alongside a net lo

### [BioLargo Reports Annual 2025 Operating and Financial Results | BLGO Stock News](https://longbridge.com/zh-CN/news/277954211.md)
*2026-03-05T06:35:00.000Z*
> BioLargo, Inc. reported its annual results for 2025, highlighting a cash balance of $3.9 million despite a net loss of $

### [Biolargo 2025 10-K: Revenue $7.8M, EPS $(0.04)](https://longbridge.com/zh-CN/news/277841198.md)
*2026-03-04T22:15:01.000Z*
> Biolargo reported a revenue decline to $7.765 million for 2025, down 56% year-over-year, resulting in a net loss of $15.

### [BioLargo, Inc. | 10-K: FY2025 Revenue Misses Estimate at USD 7.765 M](https://longbridge.com/zh-CN/news/277840538.md)
*2026-03-04T22:13:57.000Z*
### [BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time | BLGO Stock News](https://longbridge.com/zh-CN/news/277804319.md)
*2026-03-04T07:30:00.000Z*
> BioLargo, Inc. will host a webcast and conference call on March 5th, 2026, at 12:00 PM ET to discuss its Q4 2025 financi

### [BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium | BLGO Stock News](https://longbridge.com/zh-CN/news/276225647.md)
*2026-02-18T04:10:00.000Z*
> BioLargo's subsidiary, Clyra Medical Technologies, showcased ViaCLYR™'s clinical results at the Boswick Symposium, highl